Fusion Antibodies Plc (GB:FAB) has released an update.
Fusion Antibodies plc, a Belfast based CRO specializing in antibody engineering for drugs and diagnostics, is set to conduct an interactive online investor presentation on May 16th, led by CEO Dr. Adrian Kinkaid and interim CFO Stephen Smyth. Investors can register for free to join the event, which will update attendees on the company’s business and trading status, with a Q&A session to follow. The company, which has a history of successful projects with major pharmaceutical clients, aims to expedite drug development with its advanced technology platforms.
For further insights into GB:FAB stock, check out TipRanks’ Stock Analysis page.
